In the 2021 WHO classification of tumors of the central nervous system, GBM in adult-type diffuse gliomas (ADG) is defined as the absence of mutations in the isocitrate dehydrogenase gene (i.e., IDH wild-type) (3). This evidence concerns the gene IDH2 and glioblastoma.